Reported about 14 hours ago
Bain Capital is reportedly in negotiations to acquire PCI Pharma Services, a contract drug manufacturer, for a valuation of $10 billion. The discussions involve PCI's current investors, including Kohlberg & Co, Mubadala Investment Co, and Partners Group Holding AG, for a majority stake in the Philadelphia-based company that specializes in the filling and packaging of syringes and injection pens for drugmakers. Bain has also been reaching out to potential co-investors to help finance the equity portion of the deal.
Source: YAHOO